The new zinc phthalocyanine having high singlet oxygen quantum yield substituted with new benzenesulfonamide derivative groups containing schiff base

Basit Öğe Kaydı
dc.authoridPiskin, Mehmet/0000-0002-4572-4905
dc.authoridCanpolat, Erdal/0000-0002-1167-0881
dc.contributor.authorPiskin, Mehmet
dc.contributor.authorCanpolat, Erdal
dc.contributor.authorOzturk, Omer Faruk
dc.date.accessioned2025-01-27T20:50:31Z
dc.date.available2025-01-27T20:50:31Z
dc.date.issued2020
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractThe new (E)-4-((5-bromo-2-hydroxy-3-methoxybenzylidene)amino)-N-(5-methyl-1,3,4-thiadiazol-2-yl) benzenesulfonamide 1, (E)-4-((5-bromo-2-(3,4-dicyanophenoxy)-3-methoxy benzylidene)amino)-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide 2 and peripheral tetrakis-(E)-4-((5-bromo-3-methoxy-2-(lambda(1)-oxidaneyl)benzylidene) amino)-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide substituted zinc(II) phthalocyanine 3 were been synthesized and characterized using UV-vis, FT-IR, H-1 NMR, C-13 NMR (except for 3), MALDI-TOF mass spectra and elemental analysis for the first time. The spectroscopic, photophysical and photochemical properties for the phthalocyanine 3 were been described in dimethyl sulfoxide. These properties of the phthalocyanine 3 as a photosensitizer are very useful for photodynamic therapy application and its good fluorescence properties, high singlet oxygen quantum yield and appropriate photodegradation quantum yield are very important for Type II mechanisms. It has the remarkable potential to be used as Type II photosensitizers for the treatment of cancer in photodynamic therapy with these features. (C) 2019 Elsevier B.V. All rights reserved.
dc.description.sponsorshipCanakkale Onsekiz Mart University Scientific Research Projects Coordination Unit (Canakkale/Turkey) [1225, FBA-2018-1225]
dc.description.sponsorshipThis work was supported by the Canakkale Onsekiz Mart University Scientific Research Projects Coordination Unit Project ID: 1225, Project Code: FBA-2018-1225. (Canakkale/Turkey).
dc.identifier.doi10.1016/j.molstruc.2019.127181
dc.identifier.issn0022-2860
dc.identifier.issn1872-8014
dc.identifier.scopus2-s2.0-85073813310
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.molstruc.2019.127181
dc.identifier.urihttps://hdl.handle.net/20.500.12428/25514
dc.identifier.volume1202
dc.identifier.wosWOS:000501486700123
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Molecular Structure
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectsulfa drugs
dc.subjectphthalocyanine
dc.subjectphotophysical
dc.subjectphotochemical
dc.titleThe new zinc phthalocyanine having high singlet oxygen quantum yield substituted with new benzenesulfonamide derivative groups containing schiff base
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu